NCT06000605

Brief Summary

The brain is constantly active and energetically expensive, making up a quarter of the body's energy budget despite occupying only 2% of its mass. To fuel this incessant activity, the brain relies on glucose, which accommodates 99% of its metabolic needs. In most cases, glucose is the ideal fuel since it is in constant surplus owing to 24-hr access to sugar-rich food. However, the brain is metabolically flexible and capable of metabolizing alternative fuels when glucose is scarce, or, decreasing rapidly. For example, during fasting when glucose stores are dwindling, ketone bodies can supplement the brain's metabolic needs. During intense exercise, when glucose stores are being rapidly depleted, lactate - a byproduct of this glucose turnover - similarly acts as an alternative fuel for the brain. In healthy individuals, exploiting this 'brain metabolic flexibility' may be beneficial in protecting the brain from aging. The main question is: Does the brain substrate switch that occurs during fasting and high-intensity exercise underlie the beneficial effects on the brain? Young, healthy participants will fast for 3 days and complete high-intensity cycling exercise, each of which will induce a brain substrate switch. Participants will also be passively infused with ketones (to simulate fasting) and lactate (to simulate high-intensity exercise) in the fed and rested state. In doing so, the investigators will isolate the brain substrate switch from the broader, pluripotent stressors that encompass fasting and exercise. The main outcome variables are the brain biomarkers: brain-derived neurotrophic factor (BDNF) and secreted amyloid beta precursor protein (sAPPA).

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
12

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Oct 2023

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 14, 2023

Completed
7 days until next milestone

First Posted

Study publicly available on registry

August 21, 2023

Completed
1 month until next milestone

Study Start

First participant enrolled

October 1, 2023

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2024

Completed
Last Updated

August 24, 2023

Status Verified

August 1, 2023

Enrollment Period

3 months

First QC Date

August 14, 2023

Last Update Submit

August 22, 2023

Conditions

Keywords

brainBDNFmetabolismketoneslactate

Outcome Measures

Primary Outcomes (1)

  • Brain-derived neurotrophic factor, secreted amyloid beta precursor protein

    Biomarker to index neuroplasticity and resilience

    Data collected at rest, during graded infusions of lactate and ketones, pre- and post- 6 minutes of high-intensity cycling exercise

Secondary Outcomes (1)

  • Brain substrate metabolism

    Data collected at rest, during graded infusions of lactate and ketones, pre- and post- 6 minutes of high-intensity cycling exercise

Study Arms (2)

Fed

ACTIVE COMPARATOR

Exercise and passive infusions of ketones and lactate in the fed state. Participants will be fed a small meal in the middle of the protocol, also.

Other: Fed

Fasted

EXPERIMENTAL

Exercise and passive infusions of ketones and lactate in the fasted state. Participants will be required to fast for 72 hours prior to arriving to the lab for this testing arm.

Other: Fasted

Interventions

FedOTHER

Participants will eat a light meal prior to testing and be fed a light meal during testing.

Fed
FastedOTHER

Participants will completely abstain from calories for 72 hours prior to testing and not receive any calories during testing.

Fasted

Eligibility Criteria

Age19 Years - 40 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Regularly physically active, as determined via questionnaires

You may not qualify if:

  • Current smokers
  • Acute bronchial asthma, chronic obstructive airway or status asthmaticus
  • Obese (body mass index greater than 30 kg m-2)
  • Requiring daily prescription medications that may affect responses to exercise, e.g., anti-hypertensives, anti-arrhythmogenics, inhalers
  • History of disease/dysfunction that could cause complication with exercise, e.g. cardiovascular, respiratory, neurological or musculoskeletal diseases
  • Irregular or absent menstrual cycle (females)
  • Pregnant or may suspect pregnancy, or post-menopausal (females)
  • Any unexpected adverse responses to pre-experimental exercise tests
  • Any contraindication to a lumbar subarachnoid access

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of British Columbia - Okanagan Campus

Kelowna, British Columbia, V1V1V7, Canada

Location

MeSH Terms

Conditions

Metabolic DiseasesKetosis

Condition Hierarchy (Ancestors)

Nutritional and Metabolic DiseasesAcidosisAcid-Base Imbalance

Central Study Contacts

Travis D Gibbons, PhD

CONTACT

Philip N Ainslie, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
INVESTIGATOR
Masking Details
The participant will not be blinded because they must consciously adhere to study requirements, i.e., fasting for 3 days. The investigators will be blinded to the fasting and fed conditions.
Purpose
BASIC SCIENCE
Intervention Model
CROSSOVER
Model Details: Participants will complete both arms: 1) fasted and 2) fed.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

August 14, 2023

First Posted

August 21, 2023

Study Start

October 1, 2023

Primary Completion

January 1, 2024

Study Completion

January 1, 2024

Last Updated

August 24, 2023

Record last verified: 2023-08

Data Sharing

IPD Sharing
Will not share

No personal data will be made available publicly or to other researchers.

Locations